BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31958122)

  • 1. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.
    Blackford AL; Canto MI; Klein AP; Hruban RH; Goggins M
    J Natl Cancer Inst; 2020 Nov; 112(11):1162-1169. PubMed ID: 31958122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
    Chen HY; Wang X; Zhang H; Liu XB; Tan CL
    World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis.
    Li Y; Liu W; Zhao L; Xu Y; Yan T; Yang Q; Pei Q; Güngör C
    Med Sci Monit; 2020 May; 26():e921515. PubMed ID: 32358953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset pancreatic cancer: a population-based study using the SEER registry.
    Ansari D; Althini C; Ohlsson H; Andersson R
    Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study.
    Gad MM; Saad AM; Al-Husseini MJ; Abdel-Gawad YM; Alsalhani OM; Alhaddad R; Mohamad B; Saleh MA; Simons-Linares CR
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):204-210. PubMed ID: 31420297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis.
    Chhoda A; Vodusek Z; Wattamwar K; Mukherjee E; Gunderson C; Grimshaw A; Sharma A; Ahuja N; Kastrinos F; Farrell JJ
    Gastroenterology; 2022 Mar; 162(3):786-798. PubMed ID: 34813861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset pancreatic malignancies: Clinical characteristics and survival associations.
    Beeghly-Fadiel A; Luu HN; Du L; Shi C; McGavic DP; Parikh AA; Raskin L
    Int J Cancer; 2016 Nov; 139(10):2169-77. PubMed ID: 27416564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages.
    Yu J; Blackford AL; Dal Molin M; Wolfgang CL; Goggins M
    Gut; 2015 Nov; 64(11):1783-9. PubMed ID: 25636698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality.
    Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L
    BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?
    Ostapoff KT; Gabriel E; Attwood K; Kuvshinoff BW; Nurkin SJ; Hochwald SN
    HPB (Oxford); 2017 Jul; 19(7):587-594. PubMed ID: 28433254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. County-level Variation in Use of Surgery and Cancer-specific Survival for Stage I-II Pancreatic Adenocarcinoma.
    Swords DS; Mulvihill SJ; Brooke BS; Stoddard GJ; Firpo MA; Scaife CL
    Ann Surg; 2020 Dec; 272(6):1102-1109. PubMed ID: 30973391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis.
    He C; Zhang Y; Cai Z; Lin X
    BMC Cancer; 2019 May; 19(1):509. PubMed ID: 31142278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
    Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
    J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
    Chen YT; Huang ZP; Zhou ZW; He MM
    Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening.
    Hur C; Tramontano AC; Dowling EC; Brooks GA; Jeon A; Brugge WR; Gazelle GS; Kong CY; Pandharipande PV
    Pancreas; 2016 Aug; 45(7):1062-6. PubMed ID: 26692444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.